OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potassium-competitive acid blockers and gastroesophageal reflux disease
Wattana Leowattana, Tawithep Leowattana
World Journal of Gastroenterology (2022) Vol. 28, Iss. 28, pp. 3608-3619
Open Access | Times Cited: 22
Wattana Leowattana, Tawithep Leowattana
World Journal of Gastroenterology (2022) Vol. 28, Iss. 28, pp. 3608-3619
Open Access | Times Cited: 22
Showing 22 citing articles:
Vonoprazan Fumarate: A Promising Therapeutic Option for the Rapid Relief of Laryngopharyngeal Reflux Disease
Chaorong Bian, Ping Shen, Yunjin Zang, et al.
Journal of Voice (2025)
Closed Access
Chaorong Bian, Ping Shen, Yunjin Zang, et al.
Journal of Voice (2025)
Closed Access
Chitosan Nanoparticles for Gastroesophageal Reflux Disease Treatment
Yedi Herdiana
Polymers (2023) Vol. 15, Iss. 16, pp. 3485-3485
Open Access | Times Cited: 12
Yedi Herdiana
Polymers (2023) Vol. 15, Iss. 16, pp. 3485-3485
Open Access | Times Cited: 12
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect
Shupeng Zou, Mengling Ouyang, Qian Cheng, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 44, Iss. 2, pp. 171-183
Closed Access | Times Cited: 9
Shupeng Zou, Mengling Ouyang, Qian Cheng, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 44, Iss. 2, pp. 171-183
Closed Access | Times Cited: 9
Helicobacter pylori: A concise review of the latest treatments against an old foe
Wafa Ali Aldhaleei, Michael B. Wallace, Dana M. Harris, et al.
Cleveland Clinic Journal of Medicine (2024) Vol. 91, Iss. 8, pp. 481-487
Open Access | Times Cited: 3
Wafa Ali Aldhaleei, Michael B. Wallace, Dana M. Harris, et al.
Cleveland Clinic Journal of Medicine (2024) Vol. 91, Iss. 8, pp. 481-487
Open Access | Times Cited: 3
Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología
M.A. Valdovinos Díaz, Mercedes Amieva‐Balmori, Ramón Carmona-Sánchez, et al.
Revista de Gastroenterología de México (English Edition) (2024) Vol. 89, Iss. 1, pp. 121-143
Open Access | Times Cited: 2
M.A. Valdovinos Díaz, Mercedes Amieva‐Balmori, Ramón Carmona-Sánchez, et al.
Revista de Gastroenterología de México (English Edition) (2024) Vol. 89, Iss. 1, pp. 121-143
Open Access | Times Cited: 2
An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?
Georges Jourdi, Jean‐Sébastien Hulot, Pascale Gaussem
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 749-764
Closed Access | Times Cited: 2
Georges Jourdi, Jean‐Sébastien Hulot, Pascale Gaussem
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 749-764
Closed Access | Times Cited: 2
Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease
Angela Tietto, Sofia Faggin, Carmelo Scarpignato, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-16
Closed Access | Times Cited: 2
Angela Tietto, Sofia Faggin, Carmelo Scarpignato, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-16
Closed Access | Times Cited: 2
Potassium-Competitive Acid Blockers for the Treatment of Gastroesophageal Reflux Disease
Jiten P. Kothadia, Colin W. Howden
Foregut The Journal of the American Foregut Society (2023) Vol. 4, Iss. 1, pp. 7-19
Closed Access | Times Cited: 4
Jiten P. Kothadia, Colin W. Howden
Foregut The Journal of the American Foregut Society (2023) Vol. 4, Iss. 1, pp. 7-19
Closed Access | Times Cited: 4
Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología
Miguel Ángel Valdovinos-Díaz, Mercedes Amieva‐Balmori, Ramón Carmona-Sánchez, et al.
Revista de Gastroenterología de México (2024) Vol. 89, Iss. 1, pp. 121-143
Open Access | Times Cited: 1
Miguel Ángel Valdovinos-Díaz, Mercedes Amieva‐Balmori, Ramón Carmona-Sánchez, et al.
Revista de Gastroenterología de México (2024) Vol. 89, Iss. 1, pp. 121-143
Open Access | Times Cited: 1
Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial
Su Il Kim, Young Chan Lee, Wonjae Cha, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 11, pp. 5873-5883
Closed Access | Times Cited: 1
Su Il Kim, Young Chan Lee, Wonjae Cha, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 11, pp. 5873-5883
Closed Access | Times Cited: 1
Efficacy and safety of potassium-competitive acid inhibitors in the treatment of gastroesophageal reflux: a systematic review and meta-analysis
Xinxu Zhou, Hui Duan, Qian Li, et al.
Scandinavian Journal of Gastroenterology (2024) Vol. 59, Iss. 7, pp. 788-797
Open Access
Xinxu Zhou, Hui Duan, Qian Li, et al.
Scandinavian Journal of Gastroenterology (2024) Vol. 59, Iss. 7, pp. 788-797
Open Access
Advances in the Treatment of Gastroesophageal Reflux Disease
阳 高
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 1790-1797
Closed Access
阳 高
Advances in Clinical Medicine (2024) Vol. 14, Iss. 05, pp. 1790-1797
Closed Access
Impacto de los P-CABs en el tratamiento de las enfermedades relacionadas con el ácido: una revisión de la evidencia
J.M. Remes-Troche, José Luis Vargas-Basurto, Luis R. Valdovinos-García
Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana (2024) Vol. 54, Iss. 2, pp. 119-138
Open Access
J.M. Remes-Troche, José Luis Vargas-Basurto, Luis R. Valdovinos-García
Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana (2024) Vol. 54, Iss. 2, pp. 119-138
Open Access
Innovative therapeutic strategies in the treatment of gastroesophageal reflux disease (GERD): A review of progress and perspectives
Piotr Kucharczyk, Karolina Anna Parzęcka, Michał Symulewicz, et al.
Wiadomości Lekarskie (2024) Vol. 77, Iss. 6, pp. 1271-1276
Closed Access
Piotr Kucharczyk, Karolina Anna Parzęcka, Michał Symulewicz, et al.
Wiadomości Lekarskie (2024) Vol. 77, Iss. 6, pp. 1271-1276
Closed Access
Population pharmacokinetic analysis of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in patients and healthy volunteers
Eunsol Yang, Inyoung Hwang, Sang Chun Ji, et al.
CPT Pharmacometrics & Systems Pharmacology (2024)
Open Access
Eunsol Yang, Inyoung Hwang, Sang Chun Ji, et al.
CPT Pharmacometrics & Systems Pharmacology (2024)
Open Access
Fexuprazan safeguards the esophagus from hydrochloric acid-induced damage by suppressing NLRP1/Caspase-1/GSDMD pyroptotic pathway
Seo Yeon Kim, Jungho Yoon, Da Hyun Jung, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Seo Yeon Kim, Jungho Yoon, Da Hyun Jung, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Risks of anti-Helicobacter therapy and long-term therapy with antisecretory drugs
Sergey M Kotelevets
World Journal of Gastroenterology (2024) Vol. 31, Iss. 4
Closed Access
Sergey M Kotelevets
World Journal of Gastroenterology (2024) Vol. 31, Iss. 4
Closed Access
Progress of Potassium-Competitive Acid Blocker Tegoprazan in the Treatment of Acid-Related Diseases
岚 卿
Advances in Clinical Medicine (2024) Vol. 14, Iss. 08, pp. 117-122
Closed Access
岚 卿
Advances in Clinical Medicine (2024) Vol. 14, Iss. 08, pp. 117-122
Closed Access
Assessment of the Current Knowledge and Practice of General Practitioners Towards Laryngopharyngeal Reflux in Saudi Arabia
Mujtaba Alrayah, Rajab Alzahrani, Mohammed Abdullah Alghamdi, et al.
Cureus (2023)
Open Access | Times Cited: 1
Mujtaba Alrayah, Rajab Alzahrani, Mohammed Abdullah Alghamdi, et al.
Cureus (2023)
Open Access | Times Cited: 1
New achievements of pharmacology for practical medicine in prevention and therapy of acid-dependent diseases
С. В. Тихонов, Е. Н. Карева, S. Yu. Serebrova, et al.
Meditsinskiy sovet = Medical Council (2023), Iss. 8, pp. 33-40
Open Access | Times Cited: 1
С. В. Тихонов, Е. Н. Карева, S. Yu. Serebrova, et al.
Meditsinskiy sovet = Medical Council (2023), Iss. 8, pp. 33-40
Open Access | Times Cited: 1
Competitive proton pump inhibitors - status and Prospects of use
Э А Ортенберг, M. V. Lyapina, E. F. Dorodnyeva
Experimental and Clinical Gastroenterology (2023), Iss. 4, pp. 86-92
Open Access
Э А Ортенберг, M. V. Lyapina, E. F. Dorodnyeva
Experimental and Clinical Gastroenterology (2023), Iss. 4, pp. 86-92
Open Access
Medical Therapy for Gastroesophageal Reflux Disease
Jeremy A. Klein, Robert T. Kavitt
(2023), pp. 61-85
Closed Access
Jeremy A. Klein, Robert T. Kavitt
(2023), pp. 61-85
Closed Access
